Copanlisib Approved for Follicular Lymphoma

| October 16, 2017 | 0 Comments
Copanlisib Approved for Follicular Lymphoma

FDA has granted accelerated approval to copanlisib (Aliquopa®) for the treatment of patients with follicular lymphoma, a form of non-Hodgkin lymphoma.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply